The unique role of anosognosia in the clinical progression of Alzheimer’s disease: a disorder-network perspective
Abstract Alzheimer’s disease (AD) encompasses a long continuum from a preclinical phase, characterized by neuropathological alterations albeit normal cognition, to a symptomatic phase, marked by its clinical manifestations. Yet, the neural mechanisms responsible for cognitive decline in AD patients...
Saved in:
| Main Authors: | Katia Andrade, Valentina Pacella |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2024-10-01
|
| Series: | Communications Biology |
| Online Access: | https://doi.org/10.1038/s42003-024-07076-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Role of Reality Monitoring in Anosognosia for Hemiplegia
by: Paul M. Jenkinson, et al.
Published: (2010-01-01) -
Presence or absence of cognitive complaints in Parkinson’s disease: mood disorder or anosognosia?
by: Pollyanna Celso F. Castro, et al. -
Questionnaire «Opioid anosognosia» is a new tool for assessment anosognosia in opioid-dependent patients
by: R. D. Ilyuk, et al.
Published: (2025-03-01) -
Anosognosia in patients with acute hemispheric ischemic stroke
by: V. N. Grigoryeva, et al.
Published: (2016-07-01) -
Anosognosia in dementia with Lewy bodies: a systematic review
by: Victor CALIL, et al.
Published: (2021-06-01)